索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张晟 张敏 蒋利.SDF-1/CXCR7信号通路在缺血性心脏病中的作用机制与意义[J].国际心血管病杂志,2019,04:212-215.
点击复制

SDF-1/CXCR7信号通路在缺血性心脏病中的作用机制与意义(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2019年04期
页码:
212-215
栏目:
综述
出版日期:
2019-09-27

文章信息/Info

Title:
-
作者:
张晟 张敏 蒋利
上海交通大学医学院附属同仁医院心内科 200336
Author(s):
-
关键词:
基质细胞源性因子-1;  CXC趋化因子受体7;  血管新生;  缺血性心脏病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2019.04.006
文献标识码:
-
摘要:
基质细胞源性因子-1(SDF-1)/CXC趋化因子受体7(CXCR7)信号通路参与血管新生和炎性反应,在缺血性心脏病的发生发展、缺血部位的血管新生和修复过程中起重要作用。激活此通路,可提高干细胞移植成活率,改善移植治疗的效果,进而可能促进干细胞移植用于缺血性心脏病的治疗。SDF-1/CRCR7有望成为预防和治疗缺血性心脏病的新靶点。
Abstract:
-

参考文献/References

[ 1 ] Berahovich RD, Zabel BA, Lewen S, et al. Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels[J]. Immunology, 2014, 141(1):111-122.
[ 2 ] Luker KE, Steele JM, Mihalko LA, et al. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands[J]. Oncogene, 2010, 29(32):4599-4610.
[ 3 ] Zhao K, Yao Y, Luo X, et al. LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancer[J]. Carcinogenesis, 2018, 39(4):588-600.
[ 4 ] Zheng K, Li HY, Su XL, et al. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells[J]. J Exp Clin Cancer Res, 2010, 29:31.
[ 5 ] Zhang M, Qiu L, Zhang Y, et al. CXCL12 enhances angiogenesis through CXCR7 activation in human umbilical vein endothelial cells[J]. Sci Rep, 2017, 7(1):8289.
[ 6 ] Manayski Y, Doddaballapur A, Hu J, et al. Laminar flow and Klf2 regulate the paracrine activity of endothelial cells by modulating the balance of CXCR4 versus CXCR7 expression [J]. Circulation, 2014, 130(Suppl 2):18448.
[ 7 ] Suehiro J, Kanki Y, Makihara C, et al. Genome-wide approaches reveal functional vascular endothelial growth factor(VEGF)-inducible nuclear factor of activated T cells(NFAT)c1 binding to angiogenesis-related genes in the endothelium[J]. J Biol Chem, 2014, 289(42):29044-29059.
[ 8 ] Zhang XY, Su C, Cao Z, et al. CXCR7 upregulation is required for early endothelial progenitor cell-mediated endothelial repair in patients with hypertension[J]. Hypertension, 2014, 63(2):383-389.
[ 9 ] Yan X, Cai S, Xiong X, et al. Chemokine receptor CXCR7 mediates human endothelial progenitor cells survival, angiogenesis, but not proliferation[J]. J Cell Biochem, 2012, 113(4):1437-1446.
[10] Dai X, Tan Y, Cai S, et al. The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells[J]. J Cell Mol Med, 2011, 15(6):1299-1309.
[11] Li Q, Zhang A, Tao C, et al. The role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro[J]. Biochem Biophys Res Commun, 2013, 441(3):675-680.
[12] Liu H, Liu S, Li Y, et al. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury[J]. PLoS One, 2012, 7(4):e34608.
[13] Yang LX, Wei CL, Guo ML, et al. Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142[J]. Oncotarget, 2017, 8(49):85549-85558.
[14] Shiba Y, Gomibuchi T, Seto T, et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts[J]. Nature, 2016, 538(7625):388-391.
[15] Ceholski DK, Tumbull IC, Jarrah AA, et al. A unique network involving CXCR4 and CXCR7 coordinates cardiac lineage specification and mobilization of induced pluripotent stem cells[J]. Circulation, 2016, 134(Suppl 1):13277.
[16] Issa Bhaloo S, Wu Y, Le Bras A, et al. Binding of Dickkopf-3 to CXCR7 enhances vascular progenitor cell migration and degradable graft regeneration[J]. Circ Res, 2018, 123(4):451-466.
[17] Rath D, Chatterjee M, Borst O, et al. Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery[J]. Eur Heart J, 2014, 35(6):386-394.
[18] Rath D, Chatterjee M, Holtkamp A, et al. Evidence of an interaction between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in human platelets[J]. Thromb Res, 2016, 144:79-84.
[19] Chatterjee M, Rath D, Schlotterbeck J, et al. Regulation of oxidized platelet lipidome: implications for coronary artery disease[J]. Eur Heart J, 2017, 38(25):1993-2005.
[20] Li X, Zhu M, Penfold ME, et al. Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue[J]. Circulation, 2014, 129(11):1244-1253.
[21] Penn MS, Mendelsohn FO, Schaer GL, et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure[J]. Circ Res, 2013, 112(5):816-825.

备注/Memo

备注/Memo:

作者单位:上海交通大学医学院附属同仁医院心内科 200336
通信作者:蒋利,jiangli@shtrhospital.com
更新日期/Last Update: 2019-09-27